Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD

NCT03279861 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped protocol change

Conditions

Congestive Heart Failure
Hypertension

Interventions

DRUG: Entresto
DRUG: Valsartan

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]